TITLE:
Behavior Enhances Drug Reduction of Incontinence (BE-DRI)

CONDITION:
Urinary Incontinence (UI)

INTERVENTION:
Tolterodine

SUMMARY:

      The primary aim of this study is to test if the addition of behavioral treatment to drug
      therapy for the treatment of urge incontinence will increase the number of patients who can
      discontinue drug therapy and sustain a significant reduction of incontinence.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: Female
Age: 21 Years to N/A
Criteria:

        Inclusion:

          -  Female

          -  Urge predominant incontinence

          -  Incontinent > 3 mos

          -  Available for 8 mos of followup

        Exclusion:

          -  Pregnancy or < 6 mos post-partum

          -  Hypersensitivity to drug (tolterodine)

          -  Systemic disease that affects bladder function (e.g., Parkinson's disease, Multiple
             Sclerosis, spinal cord injury)

          -  History of extensive behavior treatment
      
